Financial Statements

Meridian Bioscience, Inc. (VIVO)


+0.06 (+0.19%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 1811096350-
Net Income 4271462424
Stock Dividends ----047
Dividend Paid ----11-21
Retained Earnings 2231811096350

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 49373130-
Annual Depreciation 103010434
Capital Expenditure -9-18-3-4-4
Net PPE 5149373130

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -5589114115
New Purchases -----
Intangible and Goodwill 5589114115116

Meridian Bioscience, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Meridian Bioscience, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.